Citations for
1CD84, SLAMF1, SLAMF6
Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors.
Wang N, Halibozek PJ, Yigit B, Zhao H, O'Keeffe MS, Sage P, Sharpe A, Terhorst C.
Front Immunol 6:158. doi: 10.3389/fimmu.2015.00158. eCollection 2015. 2015
2CD84, SLAMF6
B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance.
Wong EB, Soni C, Chan AY, Domeier PP, Shwetank, Abraham T, Limaye N, Khan TN, Elias MJ, Chodisetti SB, Wakeland EK, Rahman ZS.
J Immunol 194(9):4130-43. doi: 10.4049/jimmunol.1403023. Epub 2015 Mar 23. 2015
3LCK, SH2D1A, SLAMF6
SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death.
Katz G, Krummey SM, Larsen SE, Stinson JR, Snow AL.
J Immunol 192(9):4202-9. doi: 10.4049/jimmunol.1303070. Epub 2014 Mar 31. 2014
4CD84, SH2D1A, SLAMF1, SLAMF6, SLAMF7, SLAMF8
Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.
Menard L, Cantaert T, Chamberlain N, Tangye SG, Riminton S, Church JA, Klion A, Cunningham-Rundles C, Nichols KE, Meffre E.
J Allergy Clin Immunol 133(4):1149-61. doi: 10.1016/j.jaci.2013.10.051. Epub 2013 Dec 25. 2014
5SLAMF6, ZBTB16
A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes.
Dutta M, Kraus ZJ, Gomez-Rodriguez J, Hwang SH, Cannons JL, Cheng J, Lee SY, Wiest DL, Wakeland EK, Schwartzberg PL.
J Immunol 190(5):2121-8. doi: 10.4049/jimmunol.1202145. Epub 2013 Jan 25. 2013
6SH2D1A, SLAMF6
The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development.
Kageyama R, Cannons JL, Zhao F, Yusuf I, Lao C, Locci M, Schwartzberg PL, Crotty S.
Immunity 36(6):986-1002. doi: 10.1016/j.immuni.2012.05.016. Epub 2012 Jun 7. 2012
7LY9, SLAMF6
Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation.
Chatterjee M, Rauen T, Kis-Toth K, Kyttaris VC, Hedrich CM, Terhorst C, Tsokos GC.
J Immunol 188(3):1206-12. doi: 10.4049/jimmunol.1102773. Epub 2011 Dec 19. 2012
8SLAMF6
Characterization of Ly108 in the thymus: evidence for distinct properties of a novel form of Ly108.
Dutta M, Schwartzberg PL.
J Immunol 188(7):3031-41. doi: 10.4049/jimmunol.1103226. Epub 2012 Mar 5. 2012
9IL17A, LY9, RORC, SLAMF6
CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORγt recruitment to the IL17A promoter in human T lymphocytes.
Chatterjee M, Hedrich CM, Rauen T, Ioannidis C, Terhorst C, Tsokos GC.
J Biol Chem 287(45):38168-77. doi: 10.1074/jbc.M112.415067. Epub 2012 Sep 18. 2012
10SLAMF6
SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells.
Chatterjee M, Kis-Toth K, Thai TH, Terhorst C, Tsokos GC.
Autoimmunity 44(3):211-8. doi: 10.3109/08916934.2010.530627. Epub 2011 Jan 14. 2011
11SLAMF6
A novel isoform of the Ly108 gene ameliorates murine lupus.
Keszei M, Detre C, Rietdijk ST, Muņoz P, Romero X, Berger SB, Calpe S, Liao G, Castro W, Julien A, Wu YY, Shin DM, Sancho J, Zubiaur M, Morse HC 3rd, Morel L, Engel P, Wang N, Terhorst C.
J Exp Med 208(4):811-22. doi: 10.1084/jem.20101653. Epub 2011 Mar 21. 2011
12CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7
Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.
De Salort J, Sintes J, Llinās L, Matesanz-Isabel J, Engel P.
Immunol Lett 134(2):129-36. doi: 10.1016/j.imlet.2010.09.021. Epub 2010 Oct 7. 2011
13CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7, SLAMF8, SLAMF9
SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
Detre C, Keszei M, Romero X, Tsokos GC, Terhorst C.
Semin Immunopathol 32(2):157-71. Epub 2010 Feb 10.PMID: 20146065 2010
14CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7, SLAMF8, SLAMF9
The SLAM and SAP gene families control innate and adaptive immune responses.
Calpe S, Wang N, Romero X, Berger SB, Lanyi A, Engel P, Terhorst C.
Adv Immunol 97:177-250. Review.PMID: 18501771 2008
15SLAMF6
Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity.
Zhong MC, Veillette A.
J Biol Chem 283(28):19255-64. doi: 10.1074/jbc.M800209200. Epub 2008 May 15. 2008
16SLAMF6
NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family.
Cao E, Ramagopal UA, Fedorov A, Fedorov E, Yan Q, Lary JW, Cole JL, Nathenson SG, Almo SC.
Immunity 25(4):559-70. 2006
17SLAMF6
Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells.
Eissmann P, Watzl C.
J Immunol 177(5):3170-7. 2006
18CD244, SLAMF6, sLAMF7
2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.
Stark S, Watzl C.
Int Immunol 18(2):241-7. Epub 2006 Jan 12. 2006
19SLAMF6
Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions.
Howie D, Laroux FS, Morra M, Satoskar AR, Rosas LE, Faubion WA, Julien A, Rietdijk S, Coyle AJ, Fraser C, Terhorst C.
J Immunol 174(10):5931-5. 2005
20SLAMF6
NTB-A, a new activating receptor in T cells that regulates autoimmune disease.
Valdez PA, Wang H, Seshasayee D, van Lookeren Campagne M, Gurney A, Lee WP, Grewal IS.
J Biol Chem 279(18):18662-9. Epub 2004 Feb 26. 2004
21SLAMF6
Cutting edge: NTB-A activates NK cells via homophilic interaction.
Flaig RM, Stark S, Watzl C.
J Immunol 172(11):6524-7. 2004
22SLAMF6, SLAMF9
Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG, Nichols KE, Hare NJ, van de Weerdt BC.
J Immunol 171(5):2485-95. 2003
23SLAMF6, SLAMF9
Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC, Coyle A, Kingsbury GA, Terhorst C.
Immunogenetics 53(10-11):843-50. Epub 2002 Jan 23. 2002
24SLAMF6
NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.
Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD, Moretta L, Moretta A.
J Exp Med 194(3):235-46. Erratum in: J Exp Med 2001 Sep 3;194(5):following 703. 2001